Vaccitech progresses clinical development of Universal Influenza A Vaccine (VTP-100) in Belgium and Australia and expects top-line data in early 2020 Vaccitech Ltd, a clinical-stage T cell immunotherapy company developing products to treat and prevent cancer and...
–RRx-001 led to an overall survival of 21.9 months and progression-free survival of 13 months– –Data presented at the Society for Neuro-Oncology annual meeting– LA JOLLA, CA, USA I November 25, 2019 I EpicentRx, Inc., a clinical cancer...
This is the world’s first IRB-approved clinical trial aimed at reversing aging by at least 20 years; it is also the world’s most expensive pay-to-play trial with a one million price tag to enroll. MANHATTAN, Kan., Nov. 21, 2019 /PRNewswire/ — Libella...
For years Canndoc has been successfully supplying medical cannabis-based products that providing efficient treatment for children diagnosed with autism spectrum disorder Canndoc’s medicinal cannabis clinical pipeline includes 9 approved Phase 2 clinical trials...
ClearFlow, Inc., a medical device company based in Irvine, California, has announced positive clinical trial results published in the peer-reviewed Journal of Cardiothoracic Surgery. The trial evaluated the use of the PleuraFlow® Active Clearance Technology® (ACT®)...
Email
Text